Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2012
11/22/2012CA2836449A1 Kinase inhibitors
11/22/2012CA2836311A1 Amine derivatives as potassium channel blockers
11/22/2012CA2836268A1 Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process
11/22/2012CA2835835A1 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
11/22/2012CA2835169A1 Substituted indole derivatives for the treatment of immunological disorders
11/22/2012CA2834077A1 Inhibitors of bruton's tyrosine kinase
11/21/2012EP2524915A1 2-Amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors
11/21/2012EP2524913A1 Nitrogenated heterocyclic ring derivative and organic electroluminescent element comprising same
11/21/2012EP2524912A1 Amine derivatives
11/21/2012EP2523949A1 Novel substituted triazole derivatives as gamma secretase modulators
11/21/2012EP2523948A1 Pro-drugs of (e) -7- (3- (2-amino-1-fluoroethylidene) piperidin-1-yl) -1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
11/21/2012EP2523938A1 Amidoacridine derivatives useful as selective inhibitors of ubiquitin specific protease 7
11/21/2012EP2523665A1 Voltage-gated sodium channel blockers
11/21/2012CN1930127B Process for the synthesis of cxcr4 antagonist
11/21/2012CN1474803B Novel amide derivatives and medicinal use thereof
11/21/2012CN102791705A Inverse agonists and neutral antagonists for the TSH receptor
11/21/2012CN102791704A Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5)
11/21/2012CN102791703A Pyrazines as delta opioid receptor modulators
11/21/2012CN102791702A Prodrugs of [4[4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(1H-pyrrolo-pyridin-yl)-methanones and synthesis thereof
11/21/2012CN102791701A 3-(3-aminopiperidin-1-yl)-5-oxo-1,2,4-triazine derivates as dipeptidyl peptidase IV(DPP-IV) inhibitors
11/21/2012CN102791697A Amino-pyrimidine compounds as inhibitors of TBKL and/or IKK epsilon
11/21/2012CN102791695A Cyclopentyl- and cycloheptylpyrazoles as FXR modulators
11/21/2012CN102791692A Process for preparation of t-butoxycarbonylamine compounds
11/21/2012CN102791691A Compound containing pyridine ring and method for producing halogenated picoline derivative and tetrazolyloxime derivative
11/21/2012CN102791690A Di-substituted pyridine derivatives as anticancers
11/21/2012CN102791132A Plant disease control agent
11/21/2012CN102786542A Preparation method and application for potassium quinoline thifluoroborate and potassium isoquinoline thifluoroborate
11/21/2012CN102786541A Preparation method and application of potassium (iso)quinoline thifluoroborate
11/21/2012CN102786513A Omeprazole crystal E substance, its preparation method and its applications in medicines and healthcare products
11/21/2012CN102786512A N-aryl unsaturated fused ring tertiary amine compound, preparation method thereof and application thereof to tumor resistance
11/21/2012CN102786482A Akt蛋白激酶抑制剂 Akt protein kinase inhibitor
11/21/2012CN102786476A Novel compounds as opioid receptor modulators
11/21/2012CN102267980B Method for preparing 2,6-bis(2-benzimidazolyl)pyridine
11/21/2012CN102134232B Isotopically substituted proton pump inhibitor
11/21/2012CN101945861B Preparation method of phenylcarboxamides
11/21/2012CN101903342B Substituted N-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine H3 receptor modulators
11/21/2012CN101805327B Rabeprazole sodium compound and novel preparation method thereof
11/21/2012CN101792432B Pyridine chalcone derivative with aggregation sate fluorescence enhancement and two-photon fluorescence characteristics
11/21/2012CN101665484B Method for preparing lenalidomide
11/21/2012CN101643469B Synthesis process of barnidipine hydrochloride
11/21/2012CN101602708B Aryl alkanol piperidine derivative and application thereof as antidepressive medicine
11/21/2012CN101128452B Novel benzoimidazole derivatives and a pharmaceutical composition comprising the same
11/21/2012CN101018783B Quinoxaline inhibitors of the HEDGEHOG signalling pathway
11/20/2012US8314257 Treatment of CRTH2-mediated diseases and conditions
11/20/2012US8314253 Bridged tetrahydronaphthalene derivatives
11/20/2012US8314241 Process for the preparation of crystalline dexlansoprazole
11/20/2012US8314113 Substituted dihydroquinazolines II
11/20/2012US8314107 Carboxamide compounds and methods for using the same
11/20/2012US8314103 Pyridyl derivatives, their preparation and use
11/20/2012US8314099 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1 and CX3CR1
11/20/2012US8314087 Nitrogen-containing heterocyclyl ketones and methods of use
11/20/2012US8313769 Rapidly disintegrating dosage form for releasing active ingredients in the oral cavity or in body cavities
11/20/2012CA2611530C Tyrosine kinase inhibitors
11/20/2012CA2587528C Method for preparing n-phenylpyrazole-1-carboxamides
11/20/2012CA2563807C Diastereoselective synthesis process for the preparation of imidazole compounds
11/20/2012CA2563806C Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxy-quinoline
11/15/2012WO2012155085A1 Fe(ii) sequestering agents and uses thereof
11/15/2012WO2012154885A2 Carbonic anhydrase targeting agents and methods of using same
11/15/2012WO2012154760A1 Fused heterocyclic compounds as sodium channel modulators
11/15/2012WO2012154274A1 Triazolopyridine compounds as pim kinase inhibitors
11/15/2012WO2012154009A2 Thienopyrimidine derivatives, pharmaceutically acceptable salts thereof, method for preparing thienopyrimidine derivatives, and pharmaceutical composition containing thienopyrimidine derivatives as active ingredients for preventing or treating diabetes-related diseases
11/15/2012WO2012153729A1 Heteroaromatic ring derivative
11/15/2012WO2012153158A1 Process for the manufacture of dabigatran etexilate and intermediates thereof
11/15/2012WO2012152983A1 Phenyl- sulfonyl derivatives as mediators of trpa1 receptor activity for the treatment of pain
11/15/2012WO2012152855A1 Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers
11/15/2012WO2012152763A1 Substituted indazole derivatives active as kinase inhibitors
11/15/2012WO2012152644A1 Production of dense bodies (db) from hcmv-infected cells
11/15/2012WO2012125981A3 Raf kinase inhibitors
11/15/2012WO2012084852A3 Ectoparasiticidal active substance combinations
11/15/2012US20120289704 Anti-cancer compounds, synthesis thereof, and methods of using same
11/15/2012US20120289702 Nitrogen-containing heterocyclic compound and agricultural fungicide
11/15/2012US20120289700 Cyclic amine compound and acaricide
11/15/2012US20120289698 Certain heterocycles, compositions thereof, and methods for their use
11/15/2012US20120289551 Mineralocorticoid receptor antagonists
11/15/2012US20120289545 Maleate Salts of (E)-N--4-(Dimethylamino)-2-Butenamide and Crystalline Forms Thereof
11/15/2012US20120289527 Mono-hydrochloric salts of an inhibitor of histone deacetylase
11/15/2012US20120289526 Imidazolidinedione derivatives
11/15/2012US20120289507 Organic compounds as smo inhibitors
11/15/2012US20120289506 5-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same
11/15/2012US20120289505 Inhibitors of diacylglycerol acyl transferase
11/15/2012US20120289500 Potassium channel modulators
11/15/2012US20120289493 Fused heterocyclic compounds as ion channel modulators
11/15/2012US20120289403 Fluorinated Oxa or Thia Heteroarylalkylsulfide Derivatives for Combating Invertebrate Pests
11/15/2012US20120288501 Substituted benzazoles and methods of their use as inhibitors of raf kinase
11/15/2012US20120288492 NOVEL PYRIMIDINE COMPOUNDS AS mTOR AND PI3K INHIBITORS
11/15/2012US20120287524 Novel Compound, Pigment Dispersion Composition and Photosensitive Resin Composition Including the Same, and Color Filter Using the Same
11/15/2012US20120286257 Quinoxaline Derivative, and Organic Semiconductor Device, Electric Field Light Emitting Device, and Electronic Device Which have the Same
11/15/2012DE102011101446A1 Herstellung von "Dense Bodies" (DB) Production of "dense bodies" (DB)
11/15/2012CA2850576A1 Production of "dense bodies" (db) from hcmv-infected cells
11/15/2012CA2835610A1 Proteostasis regulators
11/15/2012CA2835478A1 Substituted indazole derivatives active as kinase inhibitors
11/15/2012CA2835286A1 Carbonic anhydrase targeting agents and methods of using same
11/15/2012CA2834164A1 Fused heterocyclic compounds as sodium channel modulators
11/15/2012CA2828269A1 Triazolopyridine compounds as pim kinase inhibitors
11/14/2012EP2522664A1 Piperidine derivatives as NK1 antagonists
11/14/2012EP2522662A1 Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers
11/14/2012EP2522658A1 Nitrogen-containing heterocyclic compound and agricultural/horticultural germicide
11/14/2012EP2522657A1 Indole derivative
11/14/2012EP2521721A1 3-(3-aminopiperidin-1-yl)-5-oxo-1,2,4-triazine derivates as dipeptidyl peptidase iv(dpp-iv) inhibitors
11/14/2012EP2521714A1 Sulfone compounds as 5-ht6 receptor ligands
1 ... 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 ... 1080